Start 30 days free, no card. Full Pro access for a month, then decide. Start free

Back to analysts list

Analyst

Craig Wong-Pan

RBC Capital Markets · covers Healthcare

Period: Reporting periods mapped to calendar 2024 Q3 – 2026 Q2 (8 quarters; questions recorded in 4).

Limited coverage. Only 4 questions of coverage. Treat these numbers as directional — sample too small for reliable averages.
Questions
4on tracked calls
Challenge rate
0%none of 4 questionsLimited sample
Companies
1questioned at least once
Reporting periods
4with questions

These figures cover the whole profile: every tracked question, all reporting periods.

How to read these numbers

Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.

Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.

No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.

Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.

Small samples. Profiles with fewer than 10 questions are marked Limited sample.

Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.

Questions asked

Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.

Showing 4 of 4 questions from 1 company

RMDResMed4 questions · 4 reporting periods · 0 of 4 challenging
RMD company page →

Calendar 2026 Q2

is that mainly through the price increases coming through? Or are there other factors

Show response

Aaron explained Q1 GM pressure (inflation outpacing productivity) reverses over Q2-Q4 via distribution-network optimization and modest price increases feathering in.

Calendar 2025 Q2

Just wanted to understand the Rest of World devices growth, kind of really good growth there

Revenue GrowthGeographic ExpansionTranscript · FY2025 Q4 →
Show response

Mick confirmed 10% Rest of World device growth driven by multiple factors including Japan fleet purchases and tenders. Market growth remains mid-single digits. Brett noted strong results across numerous markets including improved growth in China.

Calendar 2024 Q4

SaaS revenue growth slowed a bit from the first quarter. Could you share what the growth rates were for the different businesses

Revenue GrowthCloud & AITranscript · FY2025 Q2 →
Show response

Mick disclosed MEDIFOX growing above 8% group rate, Brightree in high-single-digits. Skilled nursing/senior living lagging post-COVID. Guided to high-single-digit top-line and double-digit NOP growth.

Calendar 2024 Q3

I just wanted to touch on the rest of world devices growth. 9% growth is good growth there

Revenue GrowthGeographic ExpansionTranscript · FY2025 Q1 →
Show response

Mick confirmed growth is predominantly volume-driven rather than ASP from AirSense 10-to-11 mix shift, with strong competitive positioning across 140 countries.

Challenge rate by company

Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.

CompanyQuestionsChallenge rate
RMD ResMed40%none of 4 questions
  • RMD
    ResMed · 4 questions
    0%none of 4 questions

Activity by reporting period

Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.

Questions by calendar reporting period
Calendar periodQuestionsChallenge rateCompanies
2024 Q310%none of 1 question1
2024 Q410%none of 1 question1
2025 Q1No questions recorded——
2025 Q210%none of 1 question1
2025 Q3No questions recorded——
2025 Q4No questions recorded——
2026 Q1No questions recorded——
2026 Q210%none of 1 question1
  1. 2024 Q31 question · challenge rate 0% (none of 1 question) · 1 company
  2. 2024 Q41 question · challenge rate 0% (none of 1 question) · 1 company
  3. 2025 Q1No questions recorded
  4. 2025 Q21 question · challenge rate 0% (none of 1 question) · 1 company
  5. 2025 Q3No questions recorded
  6. 2025 Q4No questions recorded
  7. 2026 Q1No questions recorded
  8. 2026 Q21 question · challenge rate 0% (none of 1 question) · 1 company

Topics

Topics tagged on this analyst’s questions.

  • Revenue Growth3
  • Geographic Expansion2
  • Margin1
  • Pricing1
  • Cloud & AI1